Related Experiment Videos
Clinical basis for TBI fractionation
J M Cosset1, T Girinsky, E Malaise
1Département des Radiations, Unité INSERM 247, Institut Gustave-Roussy, Villejuif, France.
Summary
Fractionated total body irradiation (TBI) appears less toxic to organs like the lungs and liver compared to single-dose TBI. However, concerns exist regarding its effectiveness in leukemia cell killing and bone marrow eradication.
Area of Science:
- Radiation Oncology
- Hematology
- Clinical Transplantation
Background:
- Total body irradiation (TBI) is a critical component of hematopoietic stem cell transplantation.
- Standard single-dose TBI (10 Gy) carries significant toxicity risks.
- Fractionated TBI regimens are being explored to mitigate toxicity.
Purpose of the Study:
- To evaluate the toxicity and efficacy of fractionated TBI compared to single-dose TBI.
- To determine optimal TBI fractionation schedules for clinical application.
Main Methods:
- Review of available clinical data on fractionated TBI regimens (12-15 Gy).
- Comparison of toxicity profiles and anti-leukemic effects with standard 10 Gy single-dose TBI.
- Consideration of data from T-depleted graft experiences.
Main Results:
- Fractionated TBI demonstrates a potential sparing effect on organs such as lungs, liver, lens, growth cartilage, and possibly the prepubertal ovary.
- Commonly used 12 Gy fractionated TBI (6 x 2 Gy) may be less effective in leukemia cell killing and recipient bone marrow eradication compared to 10 Gy single-dose TBI.
Conclusions:
- Fractionated TBI offers reduced toxicity but may compromise anti-leukemic efficacy.
- Further research, including randomized trials and large-scale retrospective studies, is needed to optimize TBI delivery and fractionation for improved outcomes in transplantation.